Evaluation of GD2 expression in patients with osteosarcoma

被引：0
|
作者：
Tarim, John [1 ]
Sowers, Rebecca S. [1 ]
Piperdi, Sajida [1 ]
Khanna, Chand [2 ]
Gorlick, Richard G. [1 ]
机构：
[1] Childrens Hosp Montefiore, Bronx, NY USA
[2] NCI, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-5332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5332
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Stereocontrolled synthesis of GD2
    Matsuzaki, Y.
    Nunomura, S.
    Ito, Y.
    Sugimoto, M.
    Nakahara, Y.
    Ogawa, T.
    Carbohydrate Research, 1993, 242
  • [32] GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
    Park, Jeong A.
    Cheung, Nai-Kong V.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [33] GD2 IS A MACROPHAGE CHECKPOINT MOLECULE AND COMBINED GD2/CD47 BLOCKADE RESULTS IN SYNERGISTIC EFFECTS AGAINST GD2 POSITIVE MALIGNANCIES
    Theruvath, Johanna
    Mount, Christopher
    Monje, Michelle
    Mackall, Crystal
    Majzner, Robbie
    NEURO-ONCOLOGY, 2020, 22 : 116 - 116
  • [34] Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells
    Yanagisawa, Makoto
    Yoshimura, Saori
    Yu, Robert K.
    ASN NEURO, 2011, 3 (02): : 69 - 74
  • [35] Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
    Erber, Ramona
    Kailayangiri, Sareetha
    Huebner, Hanna
    Ruebner, Matthias
    Hartmann, Arndt
    Haeberle, Lothar
    Meyer, Julia
    Voelkl, Simon
    Mackensen, Andreas
    Landgraf, Laura
    Geppert, Carol, I
    Schulz-Wendtland, Ruediger
    Beckmann, Matthias W.
    Fasching, Peter A.
    Farwick, Nicole
    Rossig, Claudia
    Gass, Paul
    CANCERS, 2021, 13 (21)
  • [36] EXPRESSION OF DISIALOGANGLIOSIDES GD2 AND GD3 ON HUMAN SOFT-TISSUE SARCOMAS
    CHANG, HR
    CORDONCARDO, C
    HOUGHTON, AN
    CHEUNG, NKV
    BRENNAN, MF
    CANCER, 1992, 70 (03) : 633 - 638
  • [37] Lacking immunocytological GD2 expression in neuroblastoma: Report of three cases
    Schumacher-Kuckelkorn, R
    Hero, B
    Ernestus, K
    Berthold, F
    PEDIATRIC BLOOD & CANCER, 2005, 45 (02) : 195 - 201
  • [38] GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype
    Paret, Claudia
    Ustjanzew, Arsenij
    Ersali, Sara
    Seidmann, Larissa
    Jennemann, Richard
    Ziegler, Nicole
    El Malki, Khalifa
    Russo, Alexandra
    Wingerter, Arthur
    Ortmueller, Franziska
    Bornas, Angelina
    Wehling, Pia Charlotte
    Lepadatu, Adina
    Ottenhausen, Malte
    Roth, Wilfried
    Sommer, Clemens
    Fliss, Barbara
    Frauenknecht, Katrin B. M.
    Sandhoff, Roger
    Faber, Joerg
    CANCERS, 2022, 14 (24)
  • [39] EXPRESSION OF THE GANGLIOSIDES GD3 AND GD2 ON LYMPHOCYTES IN TISSUE-SECTIONS OF MELANOMA
    HERSEY, P
    JAMAL, O
    PATHOLOGY, 1989, 21 (01) : 51 - 58
  • [40] GENETICALLY MODIFIED T CELLS SIMULTANEOUSLY TARGET HER2 AND GD2 TO ENHANCE THE CONTROL OF OSTEOSARCOMA
    Hegde, Meenakshi
    Wakefield, Amanda
    Byrd, Tiara
    Fousek, Kristen
    Yvon, Eric
    Gottschalk, Stephen
    Heslop, Helen
    Dotti, Gianpietro
    Baker, Mathew
    Ahmed, Nabil
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S6 - S6
12345